Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 15/20 | 0.37 |
| ▸ | SLC5A1 | P13866 | 5/20 | 0.37 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.36 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.36 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.36 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.36 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.36 |
| ▸ | SPHK1 | Q9NYA1 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21765115 | 0.75 | SLC5A2 (0.50) | SLC5A2SLC5A1 | |
| SCHEMBL25972545 | 0.71 | SLC5A2 (0.39) | SLC5A2SLC5A1 | |
| SCHEMBL21765097 | 0.68 | SLC5A2 (0.44) | SLC5A2SLC5A1 | |
| SCHEMBL10552933 | 0.66 | SPHK1 (0.48) | S1PR2S1PR4S1PR1S1PR3S1PR5 | |
| SCHEMBL10554369 | 0.65 | SPHK1 (0.46) | S1PR2S1PR4S1PR1S1PR3S1PR5 | |
| SCHEMBL10551984 | 0.65 | SPHK1 (0.46) | S1PR2S1PR4S1PR1S1PR3S1PR5 | |
| SCHEMBL10557377 | 0.65 | SPHK1 (0.46) | S1PR2S1PR4S1PR1S1PR3S1PR5 | |
| SCHEMBL30882853 | 0.64 | SLC5A2 (0.49) | SLC5A2SLC5A1 | |
| SCHEMBL30882854 | 0.64 | SLC5A2 (0.49) | SLC5A2SLC5A1 | |
| SCHEMBL20892222 | 0.63 | SLC5A2 (0.44) | SLC5A2SLC5A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3634970-B1 | NOVEL PROCESS FOR PREPARATION OF EMPAGLIFLOZIN OR ITS CO-CRYSTALS, SOLVATES AND THEIR POLYMORPHS THEREOF | LAURUS LABS LTD (IN) | 2023-07-19 | — | — | EP | disclosed |